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Transcranial direct current stimulation is a promising neuromodulation method for
treating depression. However, compared with pharmacological treatment, previous
studies have reported that a relatively limited proportion of patients respond to tDCS
treatment. In addition, the neurophysiological mechanisms underlying tDCS treatment
remain unclear, making it difficult to identify response predictors for tDCS treatment
based on neurophysiological function. Because treatment effects are achieved by
repetitive application of tDCS, studying the immediate effects of tDCS in depressive
patients could extend understanding of its treatment mechanisms. However, immediate
changes in a single session of tDCS are not well documented. Thus, in the current
study, we focused on the immediate impact of tDCS and its association with pre-
stimulus brain activity. To address this question, we applied anodal tDCS to the left
dorsolateral prefrontal cortex (DLPFC) or dorsomedial prefrontal cortex (DMPFC) in
14 patients with major depressive disorder (MDD) and 19 healthy controls (HCs), at
an intensity of 1.0 mA for 20 min in a single session. To evaluate anxiety, the state
trait anxiety inventory was completed before and after tDCS. We recorded resting
electroencephalography before tDCS, and calculated electrical neuronal activity in the
theta and alpha frequency bands using standardized low-resolution electromagnetic
tomography. We found that, during application of left DLPFC tDCS to patients with MDD,
the anxiety reduction effect of tDCS was related to higher baseline theta-band activity
in the rostral anterior cingulate cortex (rACC) and no medication with benzodiazepine
used as hypnotic. For DMPFC stimulation in MDD, the anxiety reduction effect was
associated with lower baseline alpha-band activity in the left inferior parietal lobule.
In contrast, in HCs, the anxiety reduction effect was associated with higher baseline
alpha activity in the precuneus during DMPFC stimulation. The current results suggest
that the association between pre-tDCS brain activity and the anxiety reduction effect of
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tDCS depends on psychopathology (depressed or non-depressed) as well as the site
of stimulation (DMPFC or left DLPFC) and insomnia. Furthermore, the results suggest
that tDCS response might be associated with baseline resting state electrophysiological
neural activity.
Keywords: transcranial direct current stimulation, left dorsolateral prefrontal cortex, dorsomedial prefrontal
cortex, anterior cingulate, anxiety, depression
INTRODUCTION
Transcranial direct current stimulation is a widely used
neuromodulation technique for basic neurocognitive
research in healthy subjects as well as clinical applications
in major depression and other psychiatric disorders (Fregni
et al., 2015; Martin et al., 2018) In clinical practice, the
development of new treatment approaches without medication
is important for patients, who show low tolerance to
pharmacotherapy because of substantial side effects (Brunoni
et al., 2012). tDCS provides a potentially useful approach
because the tDCS stimulator is a mechanically simple
device, with a lower cost than other non-invasive brain
stimulation devices.
In recent decades, major depressive disorder (MDD) has
become one of the most serious lifetime diseases in many
countries (Murray and Lopez, 1996). Although treatments for
MDD have improved, current treatment options have limitations
(Kupfer et al., 2012).
In treatment methods involving non-invasive brain
stimulation for MDD, the left dorsolateral prefrontal
cortex (DLPFC) has been found to play a major role in
executive functioning, and is widely recognized as a suitable
target for anodal tDCS to recover executive control and
emotion regulation.
A recent meta-analysis supports the application of tDCS
to the DLPFC in MDD (Mutz et al., 2018). Furthermore, a
recent large-scale study reported no inferiority of tDCS treatment
compared with escitalopram (Brunoni et al., 2017). However,
the specific treatment effects of tDCS remain controversial
(Tremblay et al., 2014; Mondino et al., 2015; Brunoni et al.,
2017; Martin et al., 2018). A recent study by Brunoni
and colleagues reported that response rates to tDCS were
significantly higher than placebo, but the remission rate was
not significantly different between tDCS and placebo groups
(Brunoni et al., 2017). Furthermore, the treatment mechanisms
of tDCS remain unclear.
Recently, several studies proposed additional targets for
treatment of MDD, suggesting non-invasive brain stimulation
of the dorsomedial prefrontal cortex (DMPFC) as one potential
approach (Downar and Daskalakis, 2013). This proposal is based
on the finding that the DMPFC, including the anterior cingulate
cortex, is involved in regulation of emotions (Bush et al., 2000),
and is anatomically connected with the amygdala and nucleus
accumbens, which have both been implicated in MDD.
More recent studies have confirmed the feasibility of rTMS
on the DMPFC for MDD (Downar et al., 2014; Kreuzer et al.,
2015; Schulze et al., 2018). However, we know little evidence of
the mechanism of DMPFC stimulation even beyond the context
of major depression (Bakker et al., 2015; Colzato et al., 2015;
Kreuzer et al., 2015).
There are several limitations of the current evidence
supporting further implementation of tDCS into clinical
practice. First, better understanding of the neurophysiological
mechanisms underlying the effects of tDCS is needed.
Second, biomarkers are needed for predicting tDCS
treatment responders. One possible approach for
addressing these current limitations is to examine the
neurophysiological signatures of patients. Specifically,
the pre-stimulus state of the brain may explain the
variability in responses to tDCS. Recent studies have
reported that pre-treatment electroencephalography (EEG)
predicts changes in cognition after 15 sessions of tDCS
in the left DLPFC in depressive patients, and that frontal
electrodes exhibit predictive power for changes in cognition
(Al-Kaysi et al., 2016, 2017).
Although predicting treatment effects with pre-treatment
neurophysiological activity would have direct implications for
clinical practice, the neurophysiological mechanisms underlying
treatment effects may remain obscured because treatment effects
are achieved by repeated application of single-session tDCS,
and the accumulation of immediate neural responses to single-
session tDCS may modify the stable state of brain activity
and eventually improve depressive symptoms. Therefore, we
assumed that examining the neural mechanisms of a single-
session of tDCS intervention might provide a first step for
disentangling the complex treatment mechanisms of tDCS for
MDD. Among symptomatic problems of MDD, single session of
tDCS is hard to change sustained symptoms such as depressive
mood, anhedonia, agitation or loss of motivation, while anxiety
is relatively volatile across time. In the current study, we
therefore focus on state anxiety to look at the effect of single-
session tDCS.
In the current study, we set two main aims. First, we
investigated the immediate effects of prefrontal tDCS on brain
activity and state anxiety. Second, we compared the effects
between stimulation of the left DLPFC, the canonical target
of tDCS for MDD, and the DMFPC, the potential target
predicted by neuroanatomical architecture. To this end, we
applied anodal tDCS to the left DLPFC or DMPFC in MDD
patients and healthy controls (HCs), with 20 min of stimulation
in a single session. We measured state anxiety before and
after tDCS and neural activity with EEG before tDCS. Finally,
we examined association between neural activity and state
anxiety to investigate neural predictors of the change in anxiety
induced by tDCS.
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MATERIALS AND METHODS
Participants
We recorded a total of 20 patients with MDD, assessed by the
DSM-IV and evaluated with the Hamilton Depression Rating
Scale (HAM-D), and a total 24 HCs subjects recruited for
this study. After eliminating data corresponding to subjects
that were left-handed, or unavailable EEG, or psychological
evaluation, 14 patients with MDD and 19 HCs were finally
included in this study. All participants were right-handed,
and were graduates of high school or higher education. All
participants were diagnosed by experienced psychiatrists
using a structured interview and physical examination. We
excluded patients with history of dementia, schizophrenia,
substance dependence, epilepsy or head trauma. Participants
do not have anxiety disorder comorbidities, such as generalized
anxiety disorder, panic disorder, and phobia. Thirteen patients
have received antidepressant. 10 patients were medicated
by benzodiazepine as sleeping medication and 2 patients
medicated by a mood stabilizer. Chi-squared test with
Yates’s correction between gender did not show significant
difference (x2(1) = 3.076, p (0.08). All HCs had no history of
psychiatry disorders. This study was carried out in accordance
with the recommendations of “Safety of transcranial direct
current stimulation, tDCS by Japanese Journal of Clinical
Neurophysiology 2011.”
The study protocol was approved by the Institutional
Ethics Review Committee of Kansai Medical University
(UMIN000015046). We obtained written informed consent from
all participants in accordance with the Declaration of Helsinki.
Participants were recruited from September 2014 to April 2017.
Details of participants are shown in Table 1.
tDCS
tDCS was administered with a battery-driven stimulator
(DC Stimulator Plus, Neuroconn, Ilmenau, Germany).
The electrical current was applied at 1 mA via electrically
conductive rubber electrodes (20 cm2, circular in shape)
attached with an adhesive conductive EEG paste. Anodal
stimulation was administered over the left-DLPFC (F5, 10–
10 EEG international electrode placement, Figure 1) or the
DMPFC (AFz, 10-10 EEG international electrode placement,
Figure 2) with the cathodal electrode placed on the left
shoulder. Direct current was administered for 20 min during
the resting state. We also simulated the current flow of our
montage with a simulation software using a finite element
model (HD-explore, Soterix Medical, New York, United
States) (Figures 1, 2).
Procedure
We adopted a between-subjects cross-over design (Figure 3).
The order of stimulation was counterbalanced. Each subject was
randomly assigned to receive left DLPFC or DMPFC tDCS in
the first session. The participant received tDCS on the other site
in the second session. There was an interval of at least 1 week
between tDCS sessions.
TABLE 1 | Demographic data.
Group MDD HC
Session Left DLPFC DMPFC Left DLPFC DMPFC
Sample size 14 19
Sex:
Male/female
12/2 12/7
Drug treatment
No 1 0
One
antidepressant
11 0
Two
antidepressants
2 0
Benzodiazepine 10 0
Mood stabilizer 2 0
Age-years:
mean ± SD
44.93 ± 14.68 48.94 ± 15.80
Education
period
15.36 ± 1.55 15.63 ± 1.34
Number of
previous
episodes:
mean ± SD
2.36 ± 0.93 0.00 ± 0.00
HAM-D17
score on the
day of the
session:
mean ± SD
14.07 ± 5.40 13.79 ± 4.82 0.21 ± 0.42 0.21 ± 0.54
FIGURE 1 | Modeling of electric field distribution for the montage of left
DLPFC stimulation. (A) Sagittal view, (B) side view, (C) above view, A: anterior,
P: posterior.
FIGURE 2 | Modeling of electric field distribution for the montage of DMPFC
stimulation. (A) Sagittal view, (B) side view, (C) above view, A: anterior, P:
posterior.
Psychological Test
We measured the STAI (state-trait anxiety inventory), which
consists of two subscales, STAI-SA for state anxiety to
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FIGURE 3 | Study design.
FIGURE 4 | Location of regions of interest (IP: inferior parietal lobe; DLPFC: dorsolateral prefrontal cortex; rACC: rostral anterior cingulate cortex; AI: anterior insula;
ITL: inferior temporal lobe).
assess anxiety before and after tDCS and STAI-TA for trait
anxiety before tDCS.
EEG Recording
Resting and eyes-closed EEG was recorded with an EEG-1200
Nihon Kohden (Tokyo, Japan) system. A 64 ch Ag/AgCl sintered
Waveguard Original EEG cap from ANT Neuro (Netherland)
was used for the recordings. It was necessary to use a subset of
the electrodes comprising of 19 EEG electrodes corresponding
to the international 10–20 system for analyses, because the tDCS
electrodes placed under the EEG cap interfered with substantial
number of EEG electrodes in the frontal area. We recorded EEG
before and after tDCS. However, only EEG recordings before
tDCS were used in the analyses described below.
EEG Analysis
Signals of cortical electric neuronal activity were computed
from the baseline, pre-stimulation EEG recordings using
standardized low resolution electromagnetic tomography
(sLORETA) (Pascual-Marqui, 2002). In its current
implementation (free academic software package available
at https://www.uzh.ch/keyinst/loreta), this method produces
signals of appropriately standardized current density from 6239
TABLE 2 | Regions of interest (ROIs) and their coordinates in the MNI space.
x y z
rACC 0 45 0
Left DLPFC −40 26 34
Right DLPFC 40 26 34
Left AI −30 24 −13.5
Right AI 30 24 −13.5
Left ITL −42 −33 −25.5
Right ITL 42 −33 −25.5
Left IPL −45 −52 48
Right IPL 45 −52 48
Precuneus 0 −66 34
rACC, rostral anterior cingulate cortex; DLPFC, dorsolateral prefrontal cortex; AI,
anterior insula; ITL, inferior temporal lobe; IPL, inferior parietal lobe.
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TABLE 3 | STAI-SA pre tDCS and STAI-SA post tDCS.
Group MDD HC
Session Left DLPFC DMPFC Left DLPFC DMPFC
STAI-
SA_pre
47.29 (±9.10) 44.71 (±8.11) 36.32 (±7.02) 35.84 (±6.80)
STAI-
SA_post
44.64 (±9.96) 43.14 (±9.81) 38.42 (±6.40) 37.16 (±6.52)
Post–Pre
change of
STAI-SA
−2.64 (±5.23) −1.57 (±6.01) 2.11 (±5.86) 1.32 (±4.35)
DLPFC, dorsolateral prefrontal cortex stimulation; DMPFC: dorsomedial prefrontal
cortex stimulation, MDD: major depressive disorder, HC: healthy controls, STAI-SA:
State-Trait Anxiety Inventory - state anxiety.
cortical gray matter voxels, sampled on a 5 mm resolution grid,
using the MNI152 anatomical template (Mazziotta et al., 2001;
Fuchs et al., 2002). sLORETA has received both theoretical
(Greenblatt et al., 2005; Sekihara et al., 2005; Pascual-Marqui,
2007) and experimental validation (Pascual-Marqui et al., 2009).
The sLORETA signals were then further processed to
produce values of cortical spectral power in two classical EEG
frequency bands: theta (4–8 Hz) and alpha (8–12 Hz). We chose
these two frequency bands because they have been repeatedly
reported to be associated with MDD and response to treatment
(Klimesch, 1999; Moore et al., 2000; Nishida et al., 2015;
Kitaura et al., 2017).
Regions of Interest
Ten regions of interest (ROIs) were chosen based on previous
studies investigating neurophysiological mechanisms in patients
with MDD (McGrath et al., 2013; Kaiser et al., 2015; Pizzagalli
et al., 2018) (Figure 4). Pizzagalli et al., investigated the
importance of current density in rACC for improvement of
depression symptoms with EEG-LORETA. The meta-analysis
by Kaiser et al., showed significant difference in resting state
TABLE 4 | Single regression analysis about STAI-SA.
Session Dependent variable Independent variable β SE β t-value p-value Standard β R2
MDD Change of STAI-SA STAI-SA pre −0.064 0.127 −0.507 0.616 −0.099 −0.028
HC Change of STAI-SA STAI-SA pre −0.339 0.111 −3.047 0.004 −0.453∗∗ 0.183
MDD, major depressive disorder; HC, healthy controls; STAI-SA, State-Trait Anxiety Inventory-state anxiety; β, the regression coefficient; SE β, standard error of the
regression coefficient; R2, the squared multiple correlation coefficient.
TABLE 5 | Log-transformed current density power at 10 ROIs in alpha and theta bands.
Group MDD HC
Session Left DLPFC DMPFC Left DLPFC DMPFC
Current density Mean SD Mean SD Mean SD Mean SD
Theta_rACC 0.186 0.518 0.133 0.570 0.521 0.519 0.400 0.454
Theta_leftDLPFC −0.380 0.459 −0.386 0.411 −0.079 0.526 −0.153 0.417
Theta_rightDLPFC −0.342 0.512 −0.258 0.480 −0.214 0.492 −0.162 0.462
Theta_leftInsula 0.072 0.528 0.070 0.437 0.478 0.491 0.346 0.361
Theta_rightInsula 0.138 0.585 0.215 0.531 0.276 0.516 0.279 0.447
Theta_lrftITP −0.350 0.413 −0.246 0.247 −0.003 0.437 −0.084 0.366
Theta_rightITP −0.328 0.467 −0.199 0.376 −0.115 0.438 −0.264 0.466
Theta_leftIPL −0.531 0.481 −0.667 0.378 −0.216 0.426 −0.119 0.618
Theta_rightIPL −0.543 0.486 −0.637 0.433 −0.253 0.481 −0.254 0.606
Theta_precuneus −0.412 0.669 −0.613 0.521 −0.175 0.467 −0.013 0.582
Alpha_rACC −0.172 0.399 −0.190 0.331 −0.017 0.406 −0.111 0.358
Alpha_leftDLPFC −0.720 0.468 −0.661 0.242 −0.484 0.331 −0.508 0.310
Alpha_rightDLPFC −0.525 0.453 −0.432 0.315 −0.636 0.409 −0.681 0.341
Alpha_leftInsula −0.056 0.545 0.009 0.230 0.157 0.273 0.039 0.292
Alpha_rightInsula 0.116 0.590 0.185 0.376 −0.028 0.311 −0.099 0.257
Alpha_lrftITP 0.233 0.794 0.535 0.494 0.381 0.614 0.299 0.592
Alpha_rightITP 0.404 0.925 0.621 0.633 0.316 0.616 0.064 0.725
Alpha_leftIPL −0.010 0.793 0.290 0.705 0.140 0.706 0.327 0.763
Alpha_rightIPL 0.173 0.857 0.460 0.706 0.210 0.612 0.179 0.793
Alpha_precuneus 0.254 0.881 0.483 0.758 0.281 0.710 0.357 0.826
DLPFC, dorsolateral prefrontal cortex; DMPFC, dorsomedial prefrontal cortex, rACC, rostral anterior cingulate cortex; AI, anterior insula; ITL, inferior temporal lobe; IPL,
inferior parietal lobe; MDD, major depressive disorder; HC, healthy controls.
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functional connectivity in patients with depression and HCs.
In addition, McGrath et al. have shown that anterior insula
and inferior temporal lobe were candidates of biomarkers of
treatment by cognitive behavior therapy by using positron
emission topography.
We defined rACC from average coordinates (i.e., centroid)
of the atlas which Pizaggali et al. used in their paper. Atlas of
DLPFC and Inferior temporal lobe in our study was obtained
from Kaiser’s literature, and the coordinates used for the anterior
insula and inferior temporal lobe originate from the work of
McGrath (McGrath et al., 2013; Table 2).
Statistical Analysis
For each stimulation session, the change in anxiety scores was
defined as the STAI-SA score at post tDCS minus the STAI-SA
score at pre tDCS (baseline). Thus, a negative value of the change
indicates a reduction of state anxiety. In the current study, we
aimed to investigate the association between these dependent
variables and cortical activities in 10 ROIs. We also included
the “with” or “without” administration of benzodiazepines as
an independent variable, and baseline STAI-SA scores for
considering the effect of the diversity of participants.
Firstly, we applied a least absolute shrinkage and selection
operator (LASSO) for selecting appropriated variables and
regularization. The set of independent variables consisted of the
cortical spectral power for the theta and alpha bands, at 10
ROIs calculated from baseline, pre-stimulation EEG-sLORETA
for each DLPFC or DMPFC session, plus the medication about
with/without benzodiazepines and STAI-SA scores at pre-tDCS
in patients and controls separately. Cross-Validation leave-one-
out was performed to determine the optimal tuning penalty
parameter (λ) for each session. Finally, variable selection was
performed by using the estimated λ value. We performed LASSO
with R (3.6.0), RStudio (1.2.1335), and glmnet package (2.0–18).
Next, forced entry multiple regression analyses were
conducted for changes in STAI-SA scores as dependent variables,
with the set of cortical activity in each theta and alpha band at
selected independent variable, for both left DLPFC and DMPFC
stimulation session, in the MDD group and in the control group.
SPSS version 26 was used for this multiple regression analysis.
Adverse Events
Six of 23 participants reported headaches, tingling sensation,
itching, or experiencing the taste of iron. Because all reported
events were mild, all participants continued the experiments and
recovered from the adverse effects immediately after the sessions.
RESULTS
Change in STAI Scores
We first examined overall changes in state anxiety. Table 3
shows the baseline and the Post–Pre tDCS changes in STAI-SA
scores (Table 3).
Analysis of variance revealed that the baseline STAI-SA score
was significantly higher in the MDD group than that in the
HC group (F[3,62] = 8.943, p < 0.001). However, analysis of
covariance revealed no significant difference in changes of STAI-
SA score between the two groups (F[1,63] = 1.562, p = 0.215),
and within each group (MDD: F[1,25] = 0.180, p = 0.675; HC:
F[1,35] = 0.397, p = 0.533). The paired t-test did not show the
significantly between the score of pre-tDCS and the one of post-
tDCS in both MDD (left DLPFC session: t = 1.67, df = 14,
p = 0.12, DMPFC session: t = 0.83, df = 14, p = 0.42) and HC
(left DLPFC session: t =−1.57, df = 18, p = 0.14, DMPFC session:
t = −1.32, df = 18, p = 0.20) groups.
In order to examine the influence of baseline STAI-SA
score on tDCS-induced changes of STAI-SA, we performed
single regression analysis where the independent variable is
the baseline STAI-SA score for each group, and the dependent
variable is as STAI-SA change (Table 4). We did not find
significant association between pre-tDCS STAI-SA score and
tDCS-induced changes of STAI-SA score in the MDD group
(p = 0.61), while it was significant in the HC group (β = −0.339,
p = 0.004). We also examined whether pre tDCS STAI-
SA score was different between the subjects treated with
benzodiazepine and those without benzodiazepine. Mann–
Whitney U-tests did not show the significant difference between
the two groups (p = 0.72).
TABLE 6 | Least absolute shrinkage and selection operator (LASSO) for selecting
appropriated variables and regularization.
Sessions Dependent
variable
Independent variable λ β
MDD on left
DLPFC
Change of
STAI-SA
Theta rACC 0.199 −0.375
Benzodiazepine −0.752
MDD on left
DLPFC
Change of
STAI-SA
Alpha left ITL 0.227 0.285
Alpha precuneus 0.187
Benzodiazepine −0.414
MDD on
DMPFC
Change of
STAI-SA
Theta left DLPFC 0.262 −0.199
Theta right insula −0.036
Theta precuneus 0.205
MDD on
DMPFC
Change of
STAI-SA
Alpha rACC 0.156 −0.018
Alpha left DLPFC −0.184
Alpha right ITL 0.114
Alpha left IPL 0.544
HC on left
DLPFC
Change of
STAI-SA
Theta n.s. 0.503 n.s.
HC on left
DLPFC
Change of
STAI-SA
Alpha n.s. 0.503 n.s.
HC on
DMPFC
Change of
STAI-SA
Theta n.s. 0.244 n.s.
HC on
DMPFC
Change of
STAI-SA
Alpha rACC 0.220 0.129
Alpha precuneus −0.403
rACC, rostral anterior cingulate cortex; DLPFC, dorsolateral prefrontal cortex; ITL,
inferior temporal lobe; IPL, inferior parietal lobe; DLPFC, dorsolateral prefrontal
cortex stimulation; DMPFC stimulation, dorsomedial prefrontal cortex; MDD, major
depressive disorder; HC, healthy controls; β, the regression coefficient; λ, tuning
penalty parameter; n.s, no significance.
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TABLE 7 | Regression analysis in each theta and alpha bands at on left DLPFC and MDD in patients and HC.
Session Dependent variable Independent variable β SE β t-value p-value Standard β R
MDD on left DLPFC Change of STAI-SA Theta rACC −5.912 1.809 −3.268 0.007∗∗ −0.586 0.583
benzodiazepine −6.281 1.998 −3.144 0.009∗∗ −0.563
MDD on left DLPFC Change of STAI-SA Alpha left ITL 2.571 1.915 1.343 0.209 0.390 0.598
Alpha Precuneus 1.728 1.725 1.002 0.340 0.291
benzodiazepine −4.181 2.039 −2.051 0.067 −0.375
MDD on DMPFC Change of STAI-SA Theta left DLPFC −6.600 6.328 −1.043 0.321 −0.451 0.327
Theta right Insula −0.428 5.022 −0.085 0.934 −0.038
Theta Precuneus 5.299 2.768 1.914 0.085 0.460
MDD on DMPFC Change of STAI-SA Alpha rACC −2.237 3.497 −0.640 0.538 −0.123 0.679
Alpha left DLPFC −6.678 4.630 −1.442 0.183 −0.268
Alpha right ITL 2.259 1.735 1.302 0.225 0.238
Alpha left IPL 5.210 1.587 3.283 0.009∗∗ 0.611
HC on left DLPFC Change of STAI-SA Theta n.s. – – – – – –
HC on left DLPFC Change of STAI-SA Alpha n.s. – – – – – –
HC on DMPFC Change of STAI-SA Theta n.s. – – – – – –
HC on DMPFC Change of STAI-SA Alpha rACC 3.416 2.349 1.454 0.165 0.282 0.481
Alpha precuneus −2.923 1.019 −2.869 0.011∗ −0.556
rACC, rostral anterior cingulate cortex; DLPFC, dorsolateral prefrontal cortex; ITL, inferior temporal lobe; IPL, inferior parietal lobe; MDD, major depressive disorder, HC;
healthy controls. ∗p < 0.05, ∗∗p < 0.01.
FIGURE 5 | Schematic summary of results in patients with MDD, based on Table 7. The red circles enclose regions with a positive slope (B > 0), and best
responders with negative STAI-change corresponded to decreased cortical activity. The blue circle encloses a region with a negative slope (B < 0), and best
responders with negative STAI-change corresponded to increased cortical activity.
Brain Activity in ROIs
We further examined pre-tDCS brain activity estimated by
sLORETA. Table 5 shows the values of brain activity calculated
by LORETA. Paired t-tests revealed no significant difference in
log-transformed current density power between the DLPFC and
DMPFC sessions, in each of the MDD and HC groups (MDD:
p = 0.299; HC: p = 0.255).
Multiple Linear Regression Models
To examine whether pre-tDCS brain activity can be associated
with anxiolytic effect, we first performed Lasso regression to
select predictor variables of each set of theta or alpha activity
(Table 6). Here we also included benzodiazepine medication
as a predictor variable to control effect of benzodiazepine
medication. We then further performed multiple regression
analysis if selected variables was associated with tDCS-
induced STAI-SA changes. Table 7 shows the results of
forced entry multiple linear regression models. Negative
values for STAI change corresponded to a reduction of state
anxiety after tDCS.
Figures 5, 6 show the schematic summaries of the MDD and
HC group with significantly difference (P < 0.05). We modeled
the change in STAI-SA scores in vertical axis, and the set of
cortical theta and alpha activity in 10 ROIs in horizonal axis for
left DLPFC and DMPFC stimulation, and in each group.
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FIGURE 6 | Schematic summary of results in the HC group, based on
Table 7. The blue circle encloses a region with a negative slope (B < 0), and
best responders with negative STAI-change corresponded to increased
cortical activity.
DISCUSSION
The current findings confirmed that, regarding the left DLPFC
stimulation site in patients with MDD, the anxiety reduction
effect of tDCS was related to higher baseline theta-band activity
in the rostral anterior cingulate cortex (rACC). In contrast,
the anxiety reduction was associated with higher baseline alpha
activity in the precuneus in the HC group.
In the current study, we have specifically focused on
immediate anxiolytic effect of tDCS, and we did not expect
to change sustained depressive symptoms. We indeed consider
accumulation of immediate anxiolytic effects will eventually lead
to long-term improvement of depressive symptoms.
The association of the anxiolytic effect of left DLPFC tDCS
with high baseline theta-band activity in the rACC is in accord
with the findings of previous studies (Arns et al., 2014; Li et al.,
2014; Bailey et al., 2018). A large scale meta-analysis studies have
further shown that functional and structural alterations in the
rACC are associated with broad spectrum of psychiatric disorders
(Goodkind et al., 2015; Sha et al., 2019). Patients with MDD
have been reported to exhibit dysfunction in the left DLPFC
as well as the rACC (Pizzagalli et al., 2002; Mayberg et al.,
2005). A study for treatment resistant depression patients who
were administered with rTMS for 4 to 7 weeks showed the
antidepressive effect was predicted by functional connectivity
between stimulation site and the subgenual cingulate (Weigand
et al., 2018). Liston and colleagues also reported that activation
of the subcallosal cingulate cortex was a main predictor for
the effect of transcranial magnetic stimulation (Liston et al.,
2014). Pizzagalli and colleagues reported that LORETA current
density of theta-band in the rACC was a predictor of response
to antidepressants. The current findings are in accord with these
previous studies, and further suggest that the rACC, including the
subcallosal cingulate cortex, is involved in the anxiolytic effects of
tDCS applied to the left DLPFC, and may appear to be important
for predicting the response of MDD patients to tDCS.
The current findings also revealed a correlation between
baseline alpha-band activity in the IPL and state anxiety
reduction during DMPFC stimulation in the MDD patient group.
Several previous studies have examined the relationship between
anxiety and functional brain imaging in IPL (Hasler et al., 2007;
Goldin et al., 2009). Importantly, the current results revealed
opposite prediction patterns in patients with MDD and HCs;
the best responding HCs (exhibiting negative STAI change)
were those with high alpha activity in precuneus in response to
DMPFC stimulation.
A study by Fox et al. suggested that the region for stimulation
by neuromodulation can be selected not only by the direct effect
of the stimulation, but also by the propagation effect, depending
on the interconnected regions of the resting state networks
(Fox et al., 2014).
As the precuneus and ACC constitute the default mode
network (Sheline et al., 2009), applying tDCS to the DMPFC
might affect activity in the precuneus, which is functionally
densely connected with the DMPFC. This association was only
found in the HC group, presumably reflecting intact functionality
of the default mode network in healthy individuals. Importantly,
other remote effects of tDCS have been reported in previous
studies. tDCS applied to the left DLPFC was reported to increase
functional connectivity in the fronto-parietal network, while
decreasing connectivity in the default mode network (van der
Werf et al., 2010; Eldaief et al., 2011). It should be noted
that anxiety disorder and depression are likely to be related
to dysfunction of this frontal-parietal network (Sylvester et al.,
2012). And this dysfunction also may yield the opposite changing
of STAI-SA; decreasing the mean score of STAI-SA in MDD and
increasing STAI-SA mean score in HCs.
Regarding the prediction of responses to tDCS treatment in
patients with MDD, Al-Kay et al. conducted a prediction analysis
with EEG data for treatment outcomes in response to prefrontal
tDCS. The results revealed that frontal EEG channels were
important for predicting mood improvement after treatment
sessions (Al-Kaysi et al., 2017). In contrast to previous studies,
the current study involved a single tDCS application, and did not
examine predictors of overall treatment, but immediate responses
to a single session of treatment. We believe determining the
immediate neurophysiological effects of tDCS is particularly
important for understanding the treatment mechanisms of
tDCS, because the accumulation of immediate changes may
eventually lead to long-term plasticity underlying the overall
treatment effects. It should also be emphasized that sLORETA
can localize activity in deeper subcortical regions, whereas scalp
EEG electrodes provide limited information about the underlying
cortical activity due to cortical surface orientation and volume
conduction effects.
Interestingly, the patients taking no benzodiazepine
medication had apparently an anxiety reduction effect for
left DLPFC stimulation; however, there was no significantly
difference pre-STAI scores between patients with and without
benzodiazepine. The results is indeed consistent with a previous
clinical trial. The clinical trial comparing the treatment response
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between tDCS and sertraline showed that benzodiazepine
decreases the effect only in the tDCS treatment group (Brunoni
et al., 2013). Benzodiazepine is used as hypnotics in this study,
thus, it might be interesting to investigate interactions between
tDCS and benzodiazepine relating to insomnia in future research.
Additionally, previous studies have reported slow EEG power
changes before and after tDCS under the tasks, which would
support further studies using slow frequencies (Keeser et al., 2011;
Wirth et al., 2011; Jacobson et al., 2012; Ulam et al., 2015).
LIMITATIONS
Our current results, demonstrating the anxiety-reducing effects
of tDCS in patients with MDD, will be of interest to researchers
and clinicians who seek to use neuromodulation techniques as
a novel treatment for depression. However, several limitations
of the current study should be noted. First, the relatively small
number of participants and no placebo stimulations may warrant
some caution in the interpretation of these results. Second,
because we applied only one stimulation, we did not examine
the therapeutic effects of tDCS on depressive symptoms. Third,
chi-squared test for gender imbalance between the MDD and
HC groups tended to be imbalanced, suggesting gender effect
may account for the difference between MDD and HC. However,
this study design also has several strengths. First, we adopted
with-in subject cross over design. Second, by adopting single-
session tDCS, we were able to reduce the total experiment time
and burden on the subjects compared with experiments involving
multiple stimulation sessions. In future research, a randomized
controlled trial of tDCS intervention with a large number of
participants would be helpful for addressing these limitations.
CONCLUSION
The current results revealed that the immediate anxiolytic effect
of left DLPFC tDCS was associated with activity in the rACC
and the left IPL, whereas DMPFC stimulation was correlated
with activity in the precuneus. These findings suggest that the
effects of tDCS are not only directly related to the stimulation
area, but also to other brain areas involved in the same
resting state networks. Further, we propose that pre-stimulus
EEG, in combination with the LORETA source estimation
analysis, provides a promising tool for predicting the outcome of
treatment intervention, including tDCS.
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